n-3 polyunsaturated fatty acid supplementation during cancer chemotherapy
Evidence from several clinical trials suggests that n-3 polyunsaturated fatty acid (n-3 PUFA) supplementation during cancer chemotherapy improves patient outcomes related to chemotherapy tolerability, regardless of the type of chemotherapy used. While the effects of n-3 PUFA supplementation during c...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-09-01
|
Series: | Journal of Nutrition & Intermediary Metabolism |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352385916300019 |